United States · 
Who invested in Poseida Therapeutics?
Poseida Therapeutics's investors include Fidelity, Perceptive Advisors, Vivo Capital, Novartis and Longitude Capital, and 8 more on record.
2020202120222023
$142MSeries C$25MRound$50MRoundUnited States · Funded startup
Who invested in Poseida Therapeutics
Funding summaryUpdated 26 Oct 2026
$217Mraised across 3 rounds since 2019, from 3 sources
$142MSeries C$25MRound$50MRound
- Latest round
- Round, $25MAug 2023
- Biggest round
- $142MSeries C · Apr 2019
- Investors
- 13 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series C, $142M Apr 2019
- Biggest round
- $142M Series C · Apr 2019
- Between rounds
- 4.3 years from the last two
The rounds
- Aug 2023Round$25M4 new1 returning
Source recordedSEC filing: $25M sold, first sale Aug 2023
- Aug 2023Round$50M1 new4 returning
Source recordedSEC filing: $25M sold, first sale Aug 2023
- Apr 2019Series C$142M8 new
- Novartis Pharma AGLead
Longitude Capital
Boxer Capital
Perceptive Ventures
Malin Corporation- Aisling
- Pentwater
- Vivo
Reported by FinSMEsSEC filing: $142M sold, first sale Mar 2019
Founders and team
From the SEC filings it signed: 5 on the team.
- Brent J. WarnerExecutive Officeri
- Harry J. LeonhardtExecutive Officeri
- Johanna M. MyletExecutive Officeri
- Kristin J. YaremaExecutive Officeri
- Mark J. GergenExecutive Officer, Directori
On the board, as filediCharles M. BaumCynthia M. CollinsJohn B. SchmidLuke M. CorningMarcea B. LloydRafael J. Amado
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series C2019Round2023Round2023Fidelity
Perceptive Advisors
Vivo Capital
NovartisLongitude CapitalNovartis Pharma AGLAdage Capital ManagementBoxer CapitalPerceptive VenturesMalin Corporation
Perceptive AdvisorsVivo CapitalNovartisLongitude CapitalNovartis Pharma AGLAdage Capital ManagementBoxer CapitalPerceptive VenturesMalin CorporationEveryone who backed them
FidelityVC firm2rounds
Novartis Pharma AGno record of our own yet1round, led 1
Adage Capital ManagementAsset manager1round
Aislingno record of our own yet1round
Pentwaterno record of our own yet1round
Vivono record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Poseida Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Poseida Therapeutics
How much has Poseida Therapeutics raised?
Poseida Therapeutics has raised $217M across 3 rounds since 2019.
When did Poseida Therapeutics last raise?
Poseida Therapeutics's most recent round was an Undisclosed round of $50M in Aug 2023.
What was Poseida Therapeutics's biggest round?
Poseida Therapeutics's largest round on record is $142M (Series C), in Apr 2019, led by Novartis Pharma AG.
Who backed Poseida Therapeutics first?
Poseida Therapeutics's first round on record, in Apr 2019, was backed by Novartis Pharma AG, Longitude Capital and Boxer Capital and 5 others.
What stage is Poseida Therapeutics at?
Poseida Therapeutics's latest named round is an Undisclosed round, in Aug 2023.
Where is Poseida Therapeutics based?
Poseida Therapeutics is based in the United States.
Who led Poseida Therapeutics's rounds?
Novartis Pharma AG led the Series C in 2019.
Companies like Poseida Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.